Skip to main content

MLAB

Stock

MLAB

Stock
Information Technology
Scientific & Technical Instruments

Performance overview

MLAB Price
Price Chart

Forward-looking statistics

Beta
0.63
Risk
52.06%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, cleaning, and chemical indicators. It also provides testing and laboratory services, mainly to the dental industry; Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions; Calibration Solutions division develops, manufactures, and sells quality control and calibration products used to measure or calibrate temperature, pressure, pH, humidity, and other such parameters for health and safety purposes; and Clinical Genomics. Its geographical segments include United States and Foreign.

Company info

SectorInformation Technology
IndustryScientific & Technical Instruments
Employees488
Market cap$565.3M

Fundamentals

Enterprise value$678.8M
Revenue$241.0M
Revenue per employee—
Profit margin-0.82%
Debt to equity121.29

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.36
Dividend per share$0.64
Revenue per share$44.45
Avg trading volume (30 day)$14M
Avg trading volume (10 day)$23M
Put-call ratio—

Macro factor sensitivity

Growth+0.1
Credit+10.8
Liquidity-3.4
Inflation-3.1
Commodities+0.8
Interest Rates-2.1

Valuation

Dividend yield0.62%
PEG Ratio14.07
Price to sales2.34
P/E Ratio14.07
Enterprise Value to Revenue2.82
Price to book3.53

Upcoming events

Next earnings dayMay 28, 2025
Next dividend day—
Ex. dividend dayMay 30, 2025

News

Mesa Labs (MLAB) Q4 Earnings and Revenues Lag Estimates

Mesa Labs (MLAB) came out with quarterly earnings of $2.23 per share, missing the Zacks Consensus Estimate of $2.75 per share. This compares to earnings of $2.77 per share a year ago.

Zacks Investment Research (May 28, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free